ATE438620T1 - Azetidin-derivate als ccr-3-rezeptor-antagonisten - Google Patents

Azetidin-derivate als ccr-3-rezeptor-antagonisten

Info

Publication number
ATE438620T1
ATE438620T1 AT05776965T AT05776965T ATE438620T1 AT E438620 T1 ATE438620 T1 AT E438620T1 AT 05776965 T AT05776965 T AT 05776965T AT 05776965 T AT05776965 T AT 05776965T AT E438620 T1 ATE438620 T1 AT E438620T1
Authority
AT
Austria
Prior art keywords
ccr
receptor antagonists
compounds
azetidine derivatives
inflammatory
Prior art date
Application number
AT05776965T
Other languages
English (en)
Inventor
Darren Mark Legrand
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE438620T1 publication Critical patent/ATE438620T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05776965T 2004-08-10 2005-08-09 Azetidin-derivate als ccr-3-rezeptor-antagonisten ATE438620T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0417801.8A GB0417801D0 (en) 2004-08-10 2004-08-10 Organic compounds
PCT/EP2005/008654 WO2006015854A2 (en) 2004-08-10 2005-08-09 Azetidine derivatives as ccr-3 receptor antagonists

Publications (1)

Publication Number Publication Date
ATE438620T1 true ATE438620T1 (de) 2009-08-15

Family

ID=33017254

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05776965T ATE438620T1 (de) 2004-08-10 2005-08-09 Azetidin-derivate als ccr-3-rezeptor-antagonisten

Country Status (17)

Country Link
US (1) US7691841B2 (de)
EP (1) EP1781606B1 (de)
JP (1) JP2008509185A (de)
KR (1) KR20070045242A (de)
CN (1) CN101175722B (de)
AT (1) ATE438620T1 (de)
AU (1) AU2005270308B2 (de)
BR (1) BRPI0514248A (de)
CA (1) CA2572748A1 (de)
DE (1) DE602005015866D1 (de)
ES (1) ES2330125T3 (de)
GB (1) GB0417801D0 (de)
MX (1) MX2007001646A (de)
PL (1) PL1781606T3 (de)
PT (1) PT1781606E (de)
RU (1) RU2007108657A (de)
WO (1) WO2006015854A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2934265B1 (fr) * 2008-07-23 2010-07-30 Sanofi Aventis Derives de carbamates d'alkylthiazoles, leur preparation et leur application en therapeutique
TW201105649A (en) * 2009-04-16 2011-02-16 Janssen Pharmaceutica Nv 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of CCR2
CN102459226B (zh) * 2009-04-17 2014-09-17 詹森药业有限公司 Ccr2的4-氮杂环丁烷基-1-杂原子连接的-环己烷拮抗剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9609374D0 (en) 1996-05-03 1996-07-10 Merck Sharp & Dohme Therapeutic agents
CA2378499A1 (en) * 1999-08-04 2001-02-15 Teijin Limited Cyclic amine ccr3 antagonists
GB0117387D0 (en) 2001-07-17 2001-09-05 Novartis Ag Organic compounds
JP2003155285A (ja) * 2001-11-19 2003-05-27 Toray Ind Inc 環状含窒素誘導体
AR041786A1 (es) * 2002-03-15 2005-06-01 Novartis Ag Derivados de azetidina como antagonistas del receptor ccr-3, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la elaboracion de un medicamento
EP1565436B1 (de) * 2002-11-27 2012-04-25 Incyte Corporation 3-aminopyrrolidinderivate als modulatoren von chemokinrezeptoren
WO2004055016A1 (en) * 2002-12-13 2004-07-01 Smithkline Beecham Corporation Pyrrolidine and azetidine compounds as ccr5 antagonists
PL1663966T3 (pl) * 2003-09-15 2007-11-30 Novartis Ag 1,3-Dipodstawione pochodne azetydyny do zastosowania jako antagoniści receptora CCR-3 w leczeniu chorób zapalnych oraz alergicznych

Also Published As

Publication number Publication date
PL1781606T3 (pl) 2010-01-29
AU2005270308B2 (en) 2009-10-22
MX2007001646A (es) 2007-04-10
BRPI0514248A (pt) 2008-06-03
EP1781606B1 (de) 2009-08-05
WO2006015854A3 (en) 2007-08-30
KR20070045242A (ko) 2007-05-02
GB0417801D0 (en) 2004-09-15
ES2330125T3 (es) 2009-12-04
DE602005015866D1 (de) 2009-09-17
EP1781606A2 (de) 2007-05-09
US7691841B2 (en) 2010-04-06
JP2008509185A (ja) 2008-03-27
RU2007108657A (ru) 2008-09-20
CN101175722A (zh) 2008-05-07
CN101175722B (zh) 2010-11-24
WO2006015854A2 (en) 2006-02-16
PT1781606E (pt) 2009-10-26
CA2572748A1 (en) 2006-02-16
AU2005270308A1 (en) 2006-02-16
US20070259848A1 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
TNSN07164A1 (en) Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
EA201001126A1 (ru) Пирролопиримидины и пирролопиридины
GB0510584D0 (en) Organic compounds
EA201001687A1 (ru) Производные имидазопиридина в качестве ингибиторов активиноподобной рецепторной киназы ( alk-4 или alk-5 )
TN2010000167A1 (en) Organic compounds
ECSP109898A (es) Compuestos orgánicos
UA92670C2 (ru) Пиразолиновые соединения и их фармацевтическое применение, композиция на их основе
GB0417910D0 (en) Organic compounds
TW200637863A (en) Organic compounds
ATE459619T1 (de) Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung
TW200745066A (en) Novel PTP1B inhibitors
MX2008001606A (es) Piperazinas substituidas como antagonistas de receptor de glutamato metabotropico.
TW200630366A (en) Organic compounds
CY1109694T1 (el) Παραγωγα πυρρολιδινης ως ανταγωνιστες υποδοχεα η3 ισταμινης
ATE541839T1 (de) Pyrrolidiniumderivate als m3-muskarinische rezeptoren
ATE473961T1 (de) Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung
DE602007004327D1 (de) Einen azepin-kern enthaltende antagonisten des histaminrezeptors
MX2009005242A (es) Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo.
ATE438620T1 (de) Azetidin-derivate als ccr-3-rezeptor-antagonisten
MXPA06002870A (es) Derivados de azetidina disubstituidos para usarse como antagonistas del receptor ccr-3 en el tratamiento de enfermedades inflamatorias y alergicas.
ATE488512T1 (de) Piperazinderivate als ccr3-hemmer
ATE488497T1 (de) Pyrrolidinderivate, die als antagonisten des ccr3-rezeptors wirken

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1781606

Country of ref document: EP